About
Sarcio develops proprietary biologic exosomes derived from induced pluripotent stem cells to promote cartilage regeneration and repair in osteoarthritic joints for applications in human and animal health.
Explore Sarcio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.